Delgocitinib Cream Study: This study tests a cream called delgocitinib for treating a skin condition called palmoplantar pustulosis (PPP), which causes pus-filled bumps on the hands and feet. The cream is applied twice daily. The study lasts for 18 weeks, involving 9 visits to the clinic.
- The study lasts 18 weeks, with 9 clinic visits.
- Participants apply the cream twice daily.
- Participants must be at least 18 years old and meet specific health criteria.
People can join if they have had PPP for over three months and meet other health conditions. However, those with certain health issues or who are pregnant cannot participate. Participants will be asked to sign a consent form. This study helps researchers understand if the cream works well and is safe for people with PPP.
How understandable was the trial content above?
Hard to understand
Easy to understand